On Friday, Merck & Co Inc (MRK) stock saw a decline, ending the day at $96.31 which represents a decrease of $-2.05 or -2.08% from the prior close of $98.36. The stock opened at $97.92 and touched a ...

The CHMP renders a positive opinion recommending approval for MRK's Keytruda for the first-line treatment of malignant ...

Moderna stock has been on a downward trajectory over the past few months, with HSBC analysts attributing the weakness to ...

Stock markets are not happy with Trump’s pick of Robert F. Kennedy Jr. to lead HHS. The SPDR Biotech ETF (XBI) lost 11.85% of its value in the last week. It traded at a low not seen since Japan’s ...

These four blue chip stocks with dependable, high-yield dividends should continue to deliver regardless of inflation.

Merck (MRK) announced that the European Medicines Agency’s Committee for Medicinal Products for Human Use, or CHMP, adopted an opinion ...

Politics will matter greatly for the biotechnology and healthcare sectors. On Thursday, President-elect Trump said that ...

Wolfe Research initiated coverage of Merck (MRK) with a Peer Perform rating. The firm said the main sentiment driver for Merck is ...

Germany’s Merck KGaA (MRK: DE) was trading 5% lower as Thursday’s activity neared its end, after the company announced its ...

Merck's undervalued stock presents growth opportunities with Keytruda and promising pipeline drugs, making it a Buy despite ...

Merck has signed a licensing agreement worth up to $3.3 billion with Shanghai-based LaNova Medicines to develop, make and ...

On Tuesday, Merck & Co Inc (MRK) stock saw a decline, ending the day at $98.58 which represents a decrease of $-2.15 or -2.13% from the prior close of $100.73. The stock opened at $100.76 and touched ...